|
Q3 2017
Filed on Nov 14, 2017
|
50,125
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
448,847
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
9,678
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
5,402
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
249,063
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
903,904
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
968,694
|
N/A
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Nov 14, 2017
|
209,864
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
3,830
|
$71.25 - $76.33
$273K - $292K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
200,000
|
$35.44 - $36.54
$7.09M - $7.31M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
21,086
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
242,357
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
35,033
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
8,511
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
69,820
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
194,123
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
6,217
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
3,150,594
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
3,882,024
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
6,026
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
10,251
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
34,910
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
95,060
|
$56.61 - $59.63
$5.38M - $5.67M
|
|
Valeant Pharmaceuticals Intl
|
Q3 2017
Filed on Nov 14, 2017
|
10,435
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
17,679
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
20,110
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
23,079
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
12,504
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
256,406
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
24,226
|
N/A
|
|